TrialBritish journal of haematology2016

Rituximab extended schedule or retreatment trial for low tumour burden non-follicular indolent B-cell non-Hodgkin lymphomas: Eastern Cooperative Oncology Group Protocol E4402.

Michael E Williams et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.